Congenital myopathy

Gene: MYMX

Green List (high evidence)

MYMX (myomixer, myoblast fusion factor)
EnsemblGeneIds (GRCh38): ENSG00000262179
EnsemblGeneIds (GRCh37): ENSG00000262179
MYMX is in 1 panel

2 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

Green List (high evidence)

Comment on phenotypes: This gene has been associated with relevant phenotypes in OMIM (MIM #619941) and the OMIM record was last accessed on 18 December 2025.
Created: 18 Dec 2025, 10:14 p.m. | Last Modified: 18 Dec 2025, 10:14 p.m.
Panel Version: 6.44
The rating of this gene has been updated to green following NHS Genomic Medicine Service approval.
Created: 11 Dec 2025, 5:32 p.m. | Last Modified: 11 Dec 2025, 5:32 p.m.
Panel Version: 6.43
Comment on list classification: There is sufficient evidence available (three unrelated cases and functional work) for the association of biallelic MYMX variants with congenital myopathy. Hence, this gene can be promoted to green rating in the next GMS update.
Created: 23 Dec 2024, 4:42 p.m. | Last Modified: 23 Dec 2024, 4:42 p.m.
Panel Version: 5.8
PMID:35642635 reported two siblings from a single pedigree with a homozygous MYMX variant (p.Arg46Ter) and with clinical presentations including weakness of the facial musculature, hypomimic face, increased overbite, micrognathia, and facial dysmorphism. Both parents were heterozygous carriers of the SNV and were unaffected. The phenotype resembles Carey-Fineman-Ziter syndrome. Functional evidence showed that the variant prevents fusion of myoblasts from patient-derived induced pluripotent stem cells and mouse model recapitulated CFZS-like phenmoptype.

PMID:39668186 reported two unrelated patients with two different homozygous MYMX variants (p.Leu36Ter & p.Ter85TrpextTer41) and with a complex neuromuscular syndrome characterized by generalized hypotonia, congenital myopathy, facial nerve palsy, growth restriction and facial dysmorphism.

This gene has been associated with relevant phenotype in OMIM ( MIM #619941), but not in Gene2Phenotype.
Created: 23 Dec 2024, 4:39 p.m. | Last Modified: 23 Dec 2024, 4:39 p.m.
Panel Version: 5.4

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
?Carey-Fineman-Ziter syndrome 2, OMIM:619941

Publications

Dmitrijs Rots (Children's Clinical University Hospital)

Green List (high evidence)

The PMID: 39668186 describes additional 2 (to previous 2; total 4) patients with congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism. Enough evidence for the green rating. Probably the gene should be added also to the short stature panel?
Sources: Literature
Created: 16 Dec 2024, 8:12 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • Expert Review Green
Phenotypes
  • Carey-Fineman-Ziter syndrome 2, OMIM:619941
  • Carey-Fineman-Ziter syndrome 2, MONDO:0100292
Tags
gene-checked
Clinvar variants
Variants in MYMX
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

18 Dec 2025, Gel status: 3

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: MYMX were changed from ?Carey-Fineman-Ziter syndrome 2, OMIM:619941 to Carey-Fineman-Ziter syndrome 2, OMIM:619941; Carey-Fineman-Ziter syndrome 2, MONDO:0100292

18 Dec 2025, Gel status: 3

Added Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag gene-checked tag was added to gene: MYMX.

11 Dec 2025, Gel status: 3

Removed Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q4_24_promote_green was removed from gene: MYMX.

11 Dec 2025, Gel status: 3

Added New Source, Added New Source, Status Update

Achchuthan Shanmugasundram (Genomics England Curator)

Source Expert Review Green was added to MYMX. Source NHS GMS was added to MYMX. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

23 Dec 2024, Gel status: 2

Entity classified by Genomics England curator

Achchuthan Shanmugasundram (Genomics England Curator)

Gene: mymx has been classified as Amber List (Moderate Evidence).

23 Dec 2024, Gel status: 0

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: MYMX were changed from congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism to ?Carey-Fineman-Ziter syndrome 2, OMIM:619941

23 Dec 2024, Gel status: 0

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: MYMX were set to PMID: 39668186

23 Dec 2024, Gel status: 0

Set mode of inheritance

Achchuthan Shanmugasundram (Genomics England Curator)

Mode of inheritance for gene: MYMX was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BIALLELIC, autosomal or pseudoautosomal

23 Dec 2024, Gel status: 0

Added Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q4_24_promote_green tag was added to gene: MYMX.

16 Dec 2024, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance

Dmitrijs Rots (Children's Clinical University Hospital)

gene: MYMX was added gene: MYMX was added to Congenital myopathy. Sources: Literature Mode of inheritance for gene: MYMX was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: MYMX were set to PMID: 39668186 Phenotypes for gene: MYMX were set to congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism Penetrance for gene: MYMX were set to Complete Review for gene: MYMX was set to GREEN